Addressing the when, what, and why of opioid craving and drug-related valuation

Affiliations

¹ Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, 5510 Nathan Shock Drive, Baltimore, MD, 21224, USA. jstric14@jhmi.edu.
² Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, 5510 Nathan Shock Drive, Baltimore, MD, 21224, USA.

Comment

Justin C Strickland et al. Neuropsychopharmacology. 2022 Jul.

. 2022 Jul;47(8):1429-1430.

doi: 10.1038/s41386-021-01261-6. Epub 2022 Jan 9.

¹ Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, 5510 Nathan Shock Drive, Baltimore, MD, 21224, USA. jstric14@jhmi.edu.
² Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, 5510 Nathan Shock Drive, Baltimore, MD, 21224, USA.

No abstract available

Conflict of interest statement

The authors declare no competing interests.

A neuroeconomic signature of opioid craving: How fluctuations in craving bias drug-related and nondrug-related value.
Biernacki K, Lopez-Guzman S, Messinger JC, Banavar NV, Rotrosen J, Glimcher PW, Konova AB. Biernacki K, et al. Neuropsychopharmacology. 2022 Jul;47(8):1440-1448. doi: 10.1038/s41386-021-01248-3. Epub 2021 Dec 16. Neuropsychopharmacology. 2022. PMID: 34916590 Free PMC article.

1. Biernacki K, Lopez-Guzman S, Messinger J, Banavar NV, Rotrosen J, Glimcher PW, et al. A neuroeconomic signature of opioid craving: how fluctuations in craving bias drug-related and nondrug-related value. Neuropsychopharmacology. 2021. 10.1038/s41386-021-01248-3. - PMC - PubMed
1. Konova AB, Louie K, Glimcher PW. The computational form of craving is a selective. multiplication of economic value. Proc Natl Acad Sci USA. 2018;115:4122–27. doi: 10.1073/pnas.1714443115. - DOI - PMC - PubMed
1. Kleykamp BA, De Santis M, Dworkin RH, Huhn AS, Kampman KM, Montoya ID, et al. Craving and opioid use disorder: a scoping review. Drug Alcohol Depend. 2019;205:107639. doi: 10.1016/j.drugalcdep.2019.107639. - DOI - PubMed
1. Epstein DH. Let’s agree to agree: a comment on Hogarth (2020), with a plea for not-so-competing theories of addiction. Neuropsychopharmacology. 2020;45:715–6. doi: 10.1038/s41386-020-0618-y. - DOI - PMC - PubMed
1. Pickard H. Is addiction a brain disease? A plea for agnosticism and heterogeneity. Psychopharmacology. 2021. 10.1007/s00213-021-06013-4. - PubMed